IntegraDose Compounding Services LLC has recalled 1,299 syringes of Vasopressin (2 Units/2 mL) in 0.9% Sodium Chloride. These compounded sterile syringes for injection were found to be sub-potent, meaning they may fail to maintain their required strength through the duration of their labeled expiration dates. This recall specifically affects medication distributed to healthcare facilities in Minnesota for office use only.
A sub-potent medication may not provide the necessary therapeutic effect to a patient. In clinical settings where vasopressin is used to maintain blood pressure, an ineffective dose could lead to inadequate treatment of life-threatening conditions.
Clinical or hospital-administered drug return
Compounded Drug Not for Resale. Office Use Only. Manufactured at 719 Kasota Ave SE, Minneapolis, MN.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.